South Africa, COVID-19, and the MMR Vaccine

According to Global Citizen, researchers from the University of Cape Town (UCT) and the University of the Witwatersrand (WITS) in South Africa have recently launched a trial to test to see if a vaccine given for measles, mumps, and rubella (MMR) can serve as an effective defense against COVID-19.

While the new effort is not an attempt to hinder current vaccine research, scientists are hoping to use it to protect individuals, like frontline healthcare workers, who have a higher probability of exposure to the vaccine than most.

Countries involved in this research effort include South Africa, Ghana, Uganda, USA, UK, and more. Read more about the vaccine trial here.

Leave a Reply

Your email address will not be published. Required fields are marked *

[mc4wp_form id=”670″]